Skip to content

Cefmenoxime

ANTIINFECTIVES FOR SYSTEMIC USE

Also known as: cefmenoxime HCl, cefmenoxime hydrochloride

OfmFDA approvedATC J01DD05ATC S01AA31ATC S02AA18

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Cefmenoxime is an ofm drug catalogued in DrugCentral. It was first approved by the FDA in 1987. DrugCentral lists 1 molecular target, including mrcA|mrcB|dacC|mrdA|ftsI|dacA|dacB.

  • Approval status: ofm (first approved 1987 by the FDA).
  • Molecular targets: mrcA|mrcB|dacC|mrdA|ftsI|dacA|dacB (1 listed in DrugCentral).
  • ATC code: J01DD05 (Third-generation cephalosporins).
  • Molecular formula: C16H17N9O5S3; molecular weight 511.55 g/mol.

Mechanism & targets

Molecular targets (1)

TargetGeneActionActivity
Bacterial penicillin-binding proteinmrcA|mrcB|dacC|mrdA|ftsI|dacA|dacBinhibitor—

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
1987-12-30FDA——

ATC classification

ATC codeTherapeutic hierarchy
J01DD05ANTIINFECTIVES FOR SYSTEMIC USE › ANTIBACTERIALS FOR SYSTEMIC USE › OTHER BETA-LACTAM ANTIBACTERIALS › Third-generation cephalosporins
S01AA31SENSORY ORGANS › OPHTHALMOLOGICALS › ANTIINFECTIVES › Antibiotics
S02AA18SENSORY ORGANS › OTOLOGICALS › ANTIINFECTIVES › Antiinfectives

Chemical structure

Molecular formulaC16H17N9O5S3
Molecular weight511.55 g/mol
CAS number65085-01-0
InChIKeyHJJDBAOLQAWBMH-YCRCPZNHSA-N
PubChem CID9570757
CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(CSC3=NN=NN3C)=C(N2C1=O)C(O)=O)C1=CSC(N)=N1

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

How does Cefmenoxime work?

Its molecular targets in DrugCentral include mrcA|mrcB|dacC|mrdA|ftsI|dacA|dacB (inhibitor).

When was Cefmenoxime first approved?

Cefmenoxime was first approved by the FDA in 1987.

What is the chemical formula of Cefmenoxime?

Cefmenoxime has the molecular formula C16H17N9O5S3 and a molecular weight of 511.55 g/mol.

Browse: all drugs starting with C · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

StatusOFM
First approval1987-12-30
AgencyFDA
Targets1
Indications0
FormulaC16H17N9O5S3
DrugCentral ID538
Interactive profile